Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.

Jadlowsky JK, Hexner EO, Marshall A, Grupp SA, Frey NV, Riley JL, Veloso E, McConville H, Rogal W, Czuczman C, Hwang WT, Li Y, Leskowitz RM, Farrelly O, Karar J, Christensen S, Barber-Rotenberg J, Gaymon A, Aronson N, Bernstein W, Melenhorst JJ, Roche AM, Everett JK, Zolnoski SA, McFarland AG, Reddy S, Petrichenko A, Cook EJ, Lee C, Gonzalez VE, Alexander K, Kulikovskaya I, Ramírez-Fernández Á, Minehart JC, Ruella M, Gill SI, Schuster SJ, Cohen AD, Garfall AL, Shah PD, Porter DL, Maude SL, Levine BL, Siegel DL, Chew A, McKenna S, Lledo L, Davis MM, Plesa G, Herbst F, Stadtmauer EA, Tebas P, DiNofia A, Haas A, Haas NB, Myers R, O'Rourke DM, Svoboda J, Tanyi JL, Aplenc R, Jacobson JM, Ko AH, Cohen RB, June CH, Bushman FD, Fraietta JA

Open source

DOI: 10.1038/s41591-024-03478-6
Published: 2025 Apr
Container: Nature medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-024-03478-6,
  title = {Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.},
  author = {Jadlowsky JK and Hexner EO and Marshall A and Grupp SA and Frey NV and Riley JL and Veloso E and McConville H and Rogal W and Czuczman C and Hwang WT and Li Y and Leskowitz RM and Farrelly O and Karar J and Christensen S and Barber-Rotenberg J and Gaymon A and Aronson N and Bernstein W and Melenhorst JJ and Roche AM and Everett JK and Zolnoski SA and McFarland AG and Reddy S and Petrichenko A and Cook EJ and Lee C and Gonzalez VE and Alexander K and Kulikovskaya I and Ramírez-Fernández Á and Minehart JC and Ruella M and Gill SI and Schuster SJ and Cohen AD and Garfall AL and Shah PD and Porter DL and Maude SL and Levine BL and Siegel DL and Chew A and McKenna S and Lledo L and Davis MM and Plesa G and Herbst F and Stadtmauer EA and Tebas P and DiNofia A and Haas A and Haas NB and Myers R and O'Rourke DM and Svoboda J and Tanyi JL and Aplenc R and Jacobson JM and Ko AH and Cohen RB and June CH and Bushman FD and Fraietta JA},
  year = {2025},
  journal = {Nature medicine},
  doi = {10.1038/s41591-024-03478-6},
  url = {https://doi.org/10.1038/s41591-024-03478-6}
}

RIS

TY  - JOUR
TI  - Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.
AU  - Jadlowsky JK
AU  - Hexner EO
AU  - Marshall A
AU  - Grupp SA
AU  - Frey NV
AU  - Riley JL
AU  - Veloso E
AU  - McConville H
AU  - Rogal W
AU  - Czuczman C
AU  - Hwang WT
AU  - Li Y
AU  - Leskowitz RM
AU  - Farrelly O
AU  - Karar J
AU  - Christensen S
AU  - Barber-Rotenberg J
AU  - Gaymon A
AU  - Aronson N
AU  - Bernstein W
AU  - Melenhorst JJ
AU  - Roche AM
AU  - Everett JK
AU  - Zolnoski SA
AU  - McFarland AG
AU  - Reddy S
AU  - Petrichenko A
AU  - Cook EJ
AU  - Lee C
AU  - Gonzalez VE
AU  - Alexander K
AU  - Kulikovskaya I
AU  - Ramírez-Fernández Á
AU  - Minehart JC
AU  - Ruella M
AU  - Gill SI
AU  - Schuster SJ
AU  - Cohen AD
AU  - Garfall AL
AU  - Shah PD
AU  - Porter DL
AU  - Maude SL
AU  - Levine BL
AU  - Siegel DL
AU  - Chew A
AU  - McKenna S
AU  - Lledo L
AU  - Davis MM
AU  - Plesa G
AU  - Herbst F
AU  - Stadtmauer EA
AU  - Tebas P
AU  - DiNofia A
AU  - Haas A
AU  - Haas NB
AU  - Myers R
AU  - O'Rourke DM
AU  - Svoboda J
AU  - Tanyi JL
AU  - Aplenc R
AU  - Jacobson JM
AU  - Ko AH
AU  - Cohen RB
AU  - June CH
AU  - Bushman FD
AU  - Fraietta JA
PY  - 2025
JO  - Nature medicine
DO  - 10.1038/s41591-024-03478-6
UR  - https://doi.org/10.1038/s41591-024-03478-6
ER  -

APA

JK, J., EO, H., A, M., SA, G., NV, F., JL, R., E, V., H, M., W, R., C, C., WT, H., Y, L., RM, L., O, F., J, K., S, C., J, B., A, G., N, A., W, B., JJ, M., AM, R., JK, E., SA, Z., AG, M., S, R., A, P., EJ, C., C, L., VE, G., K, A., I, K., Á, R., JC, M., M, R., SI, G., SJ, S., AD, C., AL, G., PD, S., DL, P., SL, M., BL, L., DL, S., A, C., S, M., L, L., MM, D., G, P., F, H., EA, S., P, T., A, D., A, H., NB, H., R, M., DM, O., J, S., JL, T., R, A., JM, J., AH, K., RB, C., CH, J., FD, B., & JA, F. (2025). Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.. Nature medicine. https://doi.org/10.1038/s41591-024-03478-6

Source records

pubmed · retrieved 2026-09-26T16:24:41.671Z